north40000
8 months ago
Not much to say, currently. SDGR shares have been in a rather steady decline since I purchased a few in May 2023. I am curious where/how the company is aiding discovery of new molecules for potential use in healthcare sector, cf. the recent Nobel Prize awards. Is this turnaround time? How proficient has the company been in its AI-aided experiments?
I have concentrated more on NVDA, IONQ, JNJ, PFE, MRK, GILD, HALO, CPRX, VCEL, WGS whose market valuations seem headed higher in our portfolios.
crudeoil24
5 years ago
Schrodinger Shares Surge 55% After IPO Priced Above High End of Range >SDGR
12:39 pm ET February 6, 2020 (Dow Jones) Print
By Colin Kellaher
Shares of Schrodinger Inc. (SDGR) jumped more than 55% in their trading debut Thursday after the drug discovery software company's upsized initial public offering of 11.9 million shares was priced at $17 apiece, above the expected range.
Schrodinger shares recently were trading at $26.54, up about 56%, after opening at $26.
The New York company, whose investors include D.E. Shaw and the Bill & Melinda Gates Foundation, previously said it planned to sell 10 million shares at $14 to $16 each in the IPO.
The company has granted the underwriters an option to buy up to 1.78 million additional shares.
crudeoil24
5 years ago
Schrodinger Inc is headquartered in New York City, New York, United States and is a software publisher. The company's key areas of interest are Computational Chemistry Software, Molecular Modeling, Dockings, Homology Modeling, Cheminformatics, Pharmacophore Modeling, Qsars, Computational Biology, Computer Chemistry, Quantum Chemistry, Software For Chemistry. The company was founded in 1995.